Paper Search Results
Home Page
More Results
Recommendations from ProNE (based on Citation Graph)
AuthorId: 2268723670
Limit: 10
Sort by: score
Embedding: s2_recommendations
IP address: 3.133.137.10
Freq flyer: False
authorId(s): 2268723670
Author(s): Wei Lu
score
citationCount
Paper
Authors
year
More like this
Compare & Contrast
ProNE-s
SciNCL
Specter
GNN
3
Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.
Dongming Liu
,
H. Mu
, ...,
Huikai Li
2023
Similar to this
Compare & Contrast
0
Hepatic artery infusion chemotherapy (HAIC) plus sintilimab and bevacizumab biosimilar (IBI305) in initial unresectable hepatocellular carcinoma (HCC): A retrospective study.
Xihao Zhang
,
Yang Liu
, ...,
Huikai Li
2024
Similar to this
Compare & Contrast
0
Durvalumab plus gemcitabine/cisplatin/nab-paclitaxel in resectable biliary tract cancer: A phase II, single-arm, open-label study (DurGAP).
Rentao Li
,
Yang Liu
, ...,
Huikai Li
2024
Similar to this
Compare & Contrast
0
A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients
Ningning Zhang
,
Wenwen Zhu
, ...,
Wei Lu
2023
Similar to this
Compare & Contrast
Help
Bulk Download
GitHub
Final Report (YouTube)
JSALT-2023
Contact us (by email)
BETA Version
